Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases

Background: Patients with multiple sclerosis (MS) often undergo complex treatment regimens, resulting in an increased risk of polypharmacy and potential drug-drug interactions (pDDIs). Drug interaction databases are useful for identifying pDDIs to support safer medication use. Objective: To compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Hecker, Michael, Frahm, Niklas, Bachmann, Paula, Debus, Jane Louisa, Haker, Marie-Celine, Mashhadiakbar, Pegah, Langhorst, Silvan Elias, Baldt, Julia, Streckenbach, Barbara, Heidler, Felicita, Zettl, Uwe Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416235/
https://www.ncbi.nlm.nih.gov/pubmed/36034780
http://dx.doi.org/10.3389/fphar.2022.946351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416235/
https://www.ncbi.nlm.nih.gov/pubmed/36034780
http://dx.doi.org/10.3389/fphar.2022.946351

Ejemplares similares